Read + Share
Amedeo Smart
Independent Medical Education
Larkin HD. Targeted Radioligand Approved for Metastatic Prostate Cancer. JAMA 2022;327:1642.PMID: 35503363
Email
LinkedIn
Facebook
Twitter
Privacy Policy
